Search Results - "Suchy, James J"

Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models by Kamoun, Walid S, Dugast, Anne-Sophie, Suchy, James J, Grabow, Stephanie, Fulton, Ross B, Sampson, James F, Luus, Lia, Santiago, Michael, Koshkaryev, Alexander, Sun, Gang, Askoxylakis, Vasileios, Tam, Eric, Huang, Zhaohua Richard, Drummond, Daryl C, Sawyer, Andrew J

“…Combinations of chemotherapy with immunotherapy have seen recent clinical success, including two approvals of anti-PD-1/L1 agents in combination with…”
Get full text

Abstract 555: A novel human TNFR2 antibody (MM-401) modulates T cell responses in anti-cancer immunity by Sampson, James F., Kurella, Vinodh B., Paragas, Violette, Kumar, Sandeep, Lulo, James E., Qiu, James A., Razlog, Maja, Fulton, Ross B., Camblin, Adam J., Richards, Jennifer M., Wong, Christina S., Koshkaryev, Alexander, Suchy, James J., Grabow, Stephanie, Muda, Marco, Raue, Andreas, Drummond, Daryl C., Tam, Eric M.

“…TNFR2 is an emerging therapeutic target in immuno-oncology. We have previously shown that an agonistic mouse TNFR2 antibody was able to activate CD8+ T cells…”
Get full text

Effects of nutritional supplementation on the progression of motor neuron degeneration in a murine model of amyotrophic lateral sclerosis by Suchy, James J

“…Amyotrophic lateral sclerosis (ALS) is a fatal disorder characterized by a loss of motor neurons that causes muscle degeneration. Factors remain elusive but…”
Get full text